Intervention

TCHP

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting2

Common conditions3

Lead sponsors shown3

Clinical trials

3 shown

RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast CancerNCT05256745 · 2023-06-06

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast CancerNCT04281641 · 2020-04-21

TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast CancerNCT04094896 · 2019-09-17

Common conditions

HER2-positive Breast Cancer2 Cancer Related Cognitive Decline1 Non-metastatic Breast Cancer1

Leading sponsors

Fudan University1 Georgetown University1 Guangdong Provincial People's Hospital1

Trial status mix

RECRUITING2

UNKNOWN1

Phase mix

PHASE22

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.